You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 4, July 27, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Health Agencies Update
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Malaria
 •Alert me on articles by topic

Malaria Vaccine Clue

Tracy Hampton, PhD

JAMA. 2005;294:418.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Researchers at the National Institute of Allergy and Infectious Diseases have discovered why individuals with a certain type of hemoglobin in their blood are less prone to severe malaria. The investigators found naturally protective effects of hemoglobin C that can impair malaria parasites (Fairhurst et al. Nature. 2005;435:1117-1121). While hemoglobin A is the most common form of hemoglobin, one fourth of individuals in parts of West Africa (where malaria is endemic) has at least one gene for hemoglobin C.

The effectiveness of malarial parasites and their ability to evade the host immune system depend on how well they can make parasitized red blood cells "sticky." For example, malarial proteins attach to red blood cells and cause the cells to stick to capillaries, which keep them from being cleared from the bloodstream. Through studies of blood drawn from children with malaria and of red blood cells infected . . . [Full Text of this Article]







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.